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Medical tourism is not a one-way street. Research shows the number of patients travelling from the UK for
treatment abroad is greater than the number coming to the UK. Johanna Hanefeld, Neil Lunt and
Richard Smith looked at effects of health tourists on the NHS and uncovered a nuanced picture
which has implications for debates around medical tourism, migration and health.
Recent public attention on immigration has included a focus on ‘health tourism’ – a term used to
denote patients travelling to the UK with the expressed purpose of accessing treatment. It has
extended to use of the NHS by recent immigrants and migrants.
In the context of wider discussion about migration, findings from our recent research on patient
mobility are of relevance. We conducted a large study which looked at effects of medical tourism
on the NHS. This involved a comprehensive look at the patients who travel and why. It included
work looking at numbers of patients, costs arising from patients travelling, potential savings to the
NHS and income from patients coming into the UK. Three specific findings seem particularly
relevant in debates around medical tourism, migration and health.
1)      A growing number of UK residents travel abroad to access treatment. While there is a long
and continuing history of patients from abroad travelling to the UK to seek medical treatment,
including in the private sector and privately from the NHS. Analysis of the International Passenger
Survey (IPS) suggests that the number of patients travelling from the UK to access treatment
abroad is greater than the number of patients travelling to the UK to access treatment (see figure
1).
Figure 1: Number of patients travelling to and from the UK to access health treatment
Source: A Cost or Benefit to the NHS?
2)      Patients who travel into the UK for private treatment in the NHS are likely to be more lucrative than private
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patients resident in the UK. Our analysis of private patient income in 27 NHS Foundation Trusts showed that almost
a quarter of their private patient income resulted from non-resident patients, even though these only accounted for
seven percent of patients.
3)      Patients who travel experience complications. Many of the people we encountered in our research did not
match the idea of an ‘empowered consumer’ or ‘tourist’ travelling for a cheap deal in an exotic destination. Many
patients had experienced challenges in accessing treatment they felt needed. They were compelled to travel to seek
better, more easily accessible or cheaper care abroad. In many cases this was a difficult decision and patients faced
challenges, including complications and need for follow-up care. In terms of costs and benefits, it may still be
cheaper for the NHS to ‘fix’ patients who have opted to pay for treatment privately abroad. However, there is an
ethical dimension to this. There is no clear guidance or regulation for medical travel. Redress in cases of malpractice
is often complex and costly to achieve, involving multiple jurisdictions.
These findings highlight several things: Medical tourism is not a one-way street. UK taxpayers travel to other
countries for treatment and as a result they may displace the local population from its own health services, or use
much needed local doctors and nurses who have been trained through the public system in the receiving country.
We need to know more about the effects of medical tourism on health systems to have an informed debate about
fairness and contributions, including in the context of foreigners’ use of the NHS.
Second, when thinking about raising private income in the NHS, patients travelling to the UK seem to be a
particularly lucrative source of income. Further detail on tariffs and billing would provide more detailed
information. Third patient mobility is not without risks, whether it is opportunistic, with intention to pay or in order to
take advantage of services abroad. It is also currently unregulated. Given the evidence that patient mobility is
increasing, this ought to be a policy priority.
Policymakers can learn from patients travelling. Outbound medical tourism from the UK tells us about the NHS:
where it fails UK residents who have an entitlement to care and treatment and who feel failed by the system and risk
complications by privately arranging to visit providers abroad, without regulation or clear safeguards.
For more on these issues read our paper Medical Tourism: A Cost or Benefit to the NHS?
Note:  This article solely gives the views of the author, and not the position of the British Politics and Policy blog, nor
of the London School of Economics. Please read our comments policy before posting. 
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